The processes that cause mutations and the development of the 30 most common cancer types have been discovered, it was announced last night.
It will have “profound implications for the understanding of cancer development," experts said.
Understanding these mutational signatures could help scientists to help treat and prevent a wide range of cancers.
Researchers from the Wellcome Trust Sanger Institute, Cambridge, UK, studied 7,042 genomes from people with the most common forms of cancer and uncovered more than 20 signatures of processes that mutate DNA. They also identified the underlying biological process responsible for many of the signatures, putting together for the first time, a comprehensive compendium of mutational processes that drive tumour development.
The findings were reported in the journal Nature.
“We have uncovered the archaeological traces within cancer genomes of the diverse mutational processes that lead to the development of most cancers,” says Professor Sir Mike Stratton, lead author and Director of the Wellcome Trust Sanger Institute.
“This compendium of mutational signatures and the consequent insights into the mutational processes underlying them has profound implications for the understanding of cancer development with potential applications in disease prevention and treatment.”
Ludmil Alexandrov, first author from the Wellcome Trust Sanger Institute, said it is known how some mutations cause cancer, such as chemicals in tobacco smoke cause mutations in lung cells that lead to lung cancers and ultraviolet light causes mutations in skin cells that lead to skin cancers. But little was known about the biological processes behind the mutations that cause most cancers to develop.
“We have identified the majority of the mutational signatures that explain the genetic development and history of cancers in patients," he said.
“We are now beginning to understand the complicated biological processes that occur over time and leave these residual mutational signatures on cancer genomes."
Their findings, which are published in Nature, found that all of the cancers contained two or more signatures but different cancers have different numbers of mutational processes: two mutational processes underlie the development of ovarian cancer, while six mutational processes lie behind the development of liver cancer.
Some mutational signatures are found in multiple cancer types, while others are confined to a single cancer type.
Out of the 30 cancer types, 25 had signatures from age-related mutational processes, while breast, ovarian and pancreatic cancers were found to be caused by defects in repairing DNA due to mutations in the breast cancer susceptibility genes BRCA1 and 2.
“Through detailed analysis, we can start to use the overwhelming amounts of information buried deep in the DNA of cancers to our advantage in terms of understanding how and why cancers arise,” says Dr Serena Nik-Zainal, of the Wellcome Trust Sanger Institute.
“Our map of the events that cause the majority of cancers in humans is an important step to discovering the processes that drive cancer formation.”
A family of enzymes, known as APOBECs, were found to be linked to more than half of the cancer types and can be activated in response to viral infections.
Ludmil B. Alexandrov, Serena Nik-Zainal, David C. Wedge, et al. Signatures of mutational processes in human cancer. Nature. 14 August 2013. DOI: 10.1038/nature12477

Leave a Reply